Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19

Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19

Multisystem inflammatory syndrome in children (MIS-C) has been widely reported in some children diagnosed with SARS-CoV-2. Clinical signs of MIS-C are manifested at 2 to 4 weeks after SARS-CoV-2 infection, where elevated biomarkers of inflammation and cardiac dysfunction are the hallmark of this syn...

Full description

Bibliographic Details
Main Authors: Diego Estrada-Luna, Elizabeth Carreón-Torres, Susana González-Reyes, María Fernanda Martínez-Salazar, María Araceli Ortiz-Rodríguez, Esther Ramírez-Moreno, José Arias-Rico, Angélica Saraí Jiménez-Osorio
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Life
Subjects:
multisystem inflammatory syndrome
children
nutraceutical compounds
Online Access:https://www.mdpi.com/2075-1729/12/10/1652

Internet

https://www.mdpi.com/2075-1729/12/10/1652

Similar Items